Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Clinical trial NCT00966277 · COMPLETED

Trial details

NCT number: NCT00966277
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pancreatic Cancer Venous Thromboembolism

Start date: 2010-04-01
Primary completion: 2014-09-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.